Research shows Orlistat typically leads to an average weight loss of 4-8% after one year
Retatrutide vs Tirzepatide Compared Retatrutide vs tirzepatide compared: 28.7% vs 22.5% weight loss, triple vs dual agonist mechanism, side effects, dosing, cost, and FDA status.
If you accept the dual evidence that GLP-1/GCGR adds 3-6 percentage points of weight loss on top of GLP-1 alone, and you accept the tirzepatide evidence that GLP-1/GIPR adds 6-8 percentage points on top of GLP-1 alone, the arithmetic of a tri-agonist that captures both effects is intuitively additive
Other symptoms: As women enter their 40s, they may experience irregular menstrual cycles, hot flushes, night sweats, mood swings, and other symptoms associated with these hormonal changes
Support Gut Health and Immunity A healthy gut is the foundation of a strong immune system
Our guide on how long peptides take to work provides more detailed timelines across conditions